Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study — Stella

Home/Bipolar Disorder/BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study

View on ClinicalTrials.gov

Recruiting

Back to Bipolar Disorder trials

BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

The Dauten Family Center for Bipolar Treatment Innovation at Massachusetts General Hospital, Boston, Massachusetts

Key details

Phase

Safety & dosing

Sponsor

Massachusetts General Hospital

Collaborators

Brain & Behavior Research Foundation, J Willard and Alice S. Marriott Foundation

Enrollment target

~30 participants

Started

January 2018

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.